JOHN SEYMOUR (MELBOURNE)
MURANO AND MRD
The design and results of the MURANO study with an emphasis on the rate of attainment,
kinetics, and prognostic impact of MRD with venetoclax & rituximab will be presented.
References:
a. Seymour et al N Engl J Med 378:1107-20, 2018
b. Kater et al J Clin Oncol 37:269-77, 2019
c. Kater et al J Clin Oncol 2020 pre-published Sep 28
